Skip to content

PHARMACHIM: what changed

Two fiscal years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.

What changed

PHARMACHIM

BE 0467.190.503
NACE 47.730, Retail sale of pharmaceutical products
fiscal year 2024 against 2025filed annual accounts (NBB)
Net result for the year
€53,894
2024 · €75,739-€21,845
Equity
€295,335
2024 · €260,274+€35,061
Cash
€129,530
2024 · €165,664-€36,134
Balance sheet total
€797,111
2024 · €712,838+€84,273

Largest movements

2024 to 2025
Assets
  • Receivables within one year +€112,655

    up €112,655 (+100.5%), from €112,069 to €224,724

    of which Trade receivables: +€119,809

  • Cash -€36,134

    down €36,134 (-21.8%), from €165,664 to €129,530

    mainly Receivables within one year (-€112,655) and Debts after one year (-€46,939)

  • Stocks and contracts +€24,966

    up €24,966 (+10.2%), from €245,786 to €270,752

  • Tangible fixed assets -€15,197

    down €15,197 (-8.2%), from €185,398 to €170,201

    of which Land and buildings: -€14,590

Equity and liabilities
  • Trade debts +€92,601

    up €92,601 (+101.7%), from €91,082 to €183,683

  • Debts after one year -€46,939

    down €46,939 (-17.5%), from €268,499 to €221,561

  • Reserves +€38,000

    up €38,000 (+15.1%), from €250,859 to €288,859

Income statement
  • Gross operating margin -€26,380

    down €26,380 (-8.0%), from €329,580 to €303,200

  • Staff costs +€13,090

    up €13,090 (+7.4%), from €176,078 to €189,169

  • Taxes -€8,688

    down €8,688 (-27.9%), from €31,100 to €22,412

  • Other operating charges -€8,059

    down €8,059 (-79.0%), from €10,196 to €2,137

From the 2024 result to the 2025 result

effect on the result

Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.

Result 2024 €75,739
Gross operating margin -€26,380
Staff costs -€13,090
Depreciation -€1,832
Other operating charges +€8,059
Financial income +€32
Financial charges +€2,679
Taxes +€8,688
Result 2025 €53,894

Cash bridge derived

cash 2024 to 2025

Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.

From operations +€31,204
Investment -€3,905
Financing -€63,434
Cash 2024 €165,664
Net result for the year +€53,894
Depreciation +€19,102
Stocks and contracts -€24,966
Receivables within one year -€112,655
Deferred charges and accrued income +€2,017
Trade debts +€92,601
Tax, wage and social debts +€318
Other debts +€1,796
Accrued charges and deferred income -€903
Investment in fixed assets (net) -€3,905
Debts after one year -€46,939
Current portion of long-term debt +€2,338
Contributions, distributions and other -€18,833
Cash 2025 €129,530
Every line side by side 47 lines
Line Code 2024 2025 Change %
Total assets 20/58 €712,838 €797,111 +€84,273 +11.8%
Fixed assets 21/28 €185,857 €170,660 -€15,197 -8.2%
Tangible fixed assets 22/27 €185,398 €170,201 -€15,197 -8.2%
Land and buildings 22 €166,054 €151,464 -€14,590 -8.8%
Plant, machinery and equipment 23 €16,975 €17,300 +€326 +1.9%
Furniture and vehicles 24 €2,369 €1,437 -€933 -39.4%
Financial fixed assets 28 €459 €459 = 0.0%
Current assets 29/58 €526,982 €626,451 +€99,470 +18.9%
Stocks and contracts in progress 3 €245,786 €270,752 +€24,966 +10.2%
Stocks 30/36 €245,786 €270,752 +€24,966 +10.2%
Amounts receivable within one year 40/41 €112,069 €224,724 +€112,655 +100.5%
Trade receivables 40 €101,516 €221,325 +€119,809 +118.0%
Other amounts receivable 41 €10,553 €3,399 -€7,154 -67.8%
Cash at bank and in hand 54/58 €165,664 €129,530 -€36,134 -21.8%
Deferred charges and accrued income 490/1 €3,462 €1,445 -€2,017 -58.2%
Total equity and liabilities 10/49 €712,838 €797,111 +€84,273 +11.8%
Equity 10/15 €260,274 €295,335 +€35,061 +13.5%
Contributions 10/11 €6,200 €6,200 = 0.0%
Reserves 13 €250,859 €288,859 +€38,000 +15.1%
Distributable reserves 133 €250,859 €288,859 +€38,000 +15.1%
Profit (loss) carried forward 14 €3,214 €276 -€2,939 -91.4%
Amounts payable 17/49 €452,564 €501,776 +€49,212 +10.9%
Amounts payable after more than one year 17 €268,499 €221,561 -€46,939 -17.5%
Financial debts 170/4 €268,499 €221,561 -€46,939 -17.5%
Amounts payable within one year 42/48 €183,083 €280,136 +€97,053 +53.0%
Current portion of amounts payable after more than one year 42 €44,601 €46,939 +€2,338 +5.2%
Trade debts 44 €91,082 €183,683 +€92,601 +101.7%
Suppliers 440/4 €91,082 €183,683 +€92,601 +101.7%
Taxes, remuneration and social security 45 €46,568 €46,886 +€318 +0.7%
Taxes 450/3 €18,297 €21,475 +€3,178 +17.4%
Remuneration and social security 454/9 €28,270 €25,411 -€2,860 -10.1%
Other amounts payable 47/48 €833 €2,629 +€1,796 +215.6%
Accrued charges and deferred income 492/3 €982 €79 -€903 -92.0%
Non-recurring operating income 76A - €7,000 +€7,000
Remuneration, social security and pensions 62 €176,078 €189,169 +€13,090 +7.4%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €17,270 €19,102 +€1,832 +10.6%
Other operating charges 640/8 €10,196 €2,137 -€8,059 -79.0%
Gross operating margin 9900 €329,580 €303,200 -€26,380 -8.0%
Operating profit (loss) 9901 €126,036 €92,793 -€33,243 -26.4%
Financial income 75/76B €482 €514 +€32 +6.6%
Recurring financial income 75 €482 €514 +€32 +6.6%
Financial charges 65/66B €19,679 €17,000 -€2,679 -13.6%
Recurring financial charges 65 €19,679 €17,000 -€2,679 -13.6%
Profit (loss) for the period before taxes 9903 €106,839 €76,306 -€30,533 -28.6%
Income taxes 67/77 €31,100 €22,412 -€8,688 -27.9%
Profit (loss) for the period 9904 €75,739 €53,894 -€21,845 -28.8%
Profit (loss) for the period to be appropriated 9905 €75,739 €53,894 -€21,845 -28.8%

Source: filed annual accounts (NBB), fiscal years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 3 October 2026 via checked.be.